HK-listed YiChang HEC rises most in 3 months on robust sales outlook

Reuters2021-06-25

** Shares of YiChang HEC ChangJiang Pharmaceutical Co Ltd rise as much as 10.9% to HK$7.94, the biggest intraday percentage gain since March 22

** Stock hits its highest since April 30; among the 30 biggest percentage gainers on the Hong Kong bourse

** Company based in central province of Hubei says its newly acquired aripiprazole and rivaroxaban tablets won bid for centralised procurement, and sales volumes are set to increase significantly

** Says improved income structure will have a positive impact on future operating performance

** The Hong Kong Hang Seng Commerce & Industry Index rises 1.5%

** The Hang Seng China Enterprises Index climbs 1.4% and the benchmark index gains 1.1%

** By last close, the stock had fallen 18.9% this year

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • KHW
    2021-06-25
    KHW
    Good
  • THong
    2021-06-25
    THong
    Nice ..however it is a downtrending chart..hopefully it can pick-up soon.
  • fionacheng
    2021-06-25
    fionacheng
    Yooo
  • GoG
    2021-06-25
    GoG
    Ok
  • KKYONG
    2021-06-25
    KKYONG
    Great
  • T0000024852
    2021-06-25
    T0000024852
    Hi
Leave a comment
9